The largest U.S. drugmaker agreed to pay a hefty premium of 62% for Array, which sells the combination treatment Braftovi and Mektovi for melanoma. But those drugs appear poised to become part of a promising triple combination for advanced colorectal cancer.
from Moneycontrol http://bit.ly/2XnSnJr
Finding symbol of isotops by proton and neutron
-
Reactions of Diazonium Salts: Sandmeyer and Related Reactions by Nand kishor gupta in AMINES , AROMATIC REACTIONS , ORGANIC CHEM...
-
Three Visual “Tests” For The Presence of Aldehydes: Benedict’s, Fehlings, and Tollens’ Tests We’ve seen previously that aldehydes are a fun... -
Since the bifurcation (October 31), as many as 45 lakh beneficiaries have got Rs 1,705 crore disbursed through direct benefit transfers to t...
No comments:
Post a Comment